Ucrainenii de la Biopharma își dublează investiția în fabrica de medicamente de la Oradea

Ukrainian pharmaceutical company Biopharma is doubling its investment in Oradea, with the first phase costing 85 million euros. This amount exceeds the initial minimum announced in 2024. The project will be executed in four phases, with the first phase already underway, including the construction of the facility and the ordering of production equipment. The factory will process up to 1.2 million liters of frozen human plasma annually, located in the Eurobusiness I Industrial Park.